Vimarsana
Biggest News Aggregation in the World

Page 21 - Robert Blum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Blum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Blum Today - Breaking & Trending Today

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Vimarsana News

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules

PONTE VEDRA, Fla., July 12, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., ("Cadrenal" or the "Company") (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood

Open Mainframe Project Announces Schedule for Open Mainframe Summit Las Vegas on September 11 - Vimarsana News

Open Mainframe Project Announces Schedule for Open Mainframe Summit Las Vegas on September 11

/PRNewswire/ -- The Open Mainframe Project, an open source initiative that enables collaboration across the mainframe community to develop shared tool sets and...

How Jewish educators can address the youth mental health crisis - Vimarsana News

How Jewish educators can address the youth mental health crisis

Jewish values, teachings and practices can help build up emotional resilience in teenagers

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Vimarsana News

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules

PONTE VEDRA, Fla., July 12, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant for certain...

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Vimarsana News

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules

/PRNewswire/ -- Cadrenal Therapeutics, Inc., ("Cadrenal" or the "Company") (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage novel...